Background Surgical site infections (SSI) following spine surgery significantly impact patient morbidity and mortality. Antibacterial prophylaxis (AP) using cefazolin is a key strategy for preventing SSI.
Aim. This observational study aimed to examine the pharmacokinetics of guideline-recommended cefazolin AP in spine surgery.
Methods. Nine patients (aged 50 ± 14 years, renal function 99 ± 30 mL/min/72kg) undergoing spine surgery received AP with 2 g cefazolin. Blood samples were collected at 5, 10, 30, 60 and 90 minutes intraoperatively for measuring total cefazolin concentrations by high performance liquid chromatography. Patients were monitored for SSI during and post-hospitalization. Total cefazolin concentrations at wound closure were compared to the target concentrations of \(\geq\) 40 mg/L.
Results. The interval between cefazolin administration and wound closure ranged between 40 and 190 minutes. Total plasma cefazolin concentrations peaked at 214 ± 35 mg/L −1 within 15 minutes following cefazolin dose. Total plasma cefazolin concentrations at wound closure were 68 ± 30 mg/L −1. 12.5 percent of cefazolin concentrations at wound closure were less than 40 mg/L. Longer surgery duration was associated with below-target concentrations. None of the patients in the study developed SSI.
Conclusion. The study demonstrates that current intraoperative AP with cefazolin achieves target plasma concentrations in the majority of patients. Duration of surgery is a critical factor in considering alternative dosing regimens.